Bridgepoint buys European dialysis group(2)

EQT and Investor make a quick return on their €4.3 billiion acquisition of medical technology group Gambro, selling Gambro Healthcare to mid-market rival Bridgepoint less than a year after acquisition

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this